Paul Battle - LDN and Crohn's Disease (2014 Conference) (LDN, low dose naltrexone)
Paul Battle, PA-C discusses the limitations of traditional treatment and failures in diagnosis for Crohn’s disease and why Low Dose Naltrexone (LDN) is the ideal drug for this debilitating disease and why it should be prescribed more often.
Paul obtained his bachelor of science degree in Physiology from the University of California Davis. He completed his Physician Assistant training at Emory University School of Medicine in 1981. He has practiced for over 30 years in 10 different specialties around the United States.
He was introduced to Low Dose Naltrexone (LDN) in 2007 reading Dr. Jill Smith’s article about low dose naltrexone and Crohn’s disease. Unfortunately his 10-year-old son was diagnosed with severe Crohn’s disease. In 2007 his son had an acute exacerbation where low dose naltrexone saved his life. Since that time Paul’s mission has been to educate many people about Low Dose Naltrexone.
For more conference presentations please visit https://ldnresearchtrust.org/ldn-conferences